Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 9
2004 5
2005 5
2006 12
2007 8
2008 10
2009 15
2010 8
2011 9
2012 14
2013 13
2014 12
2015 17
2016 13
2017 14
2018 12
2019 6
2020 5
Text availability
Article attribute
Article type
Publication date

Search Results

161 results
Results by year
Filters applied: . Clear all
Page 1
Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.
André F, Ciruelos E, Rubovszky G, Campone M, Loibl S, Rugo HS, Iwata H, Conte P, Mayer IA, Kaufman B, Yamashita T, Lu YS, Inoue K, Takahashi M, Pápai Z, Longin AS, Mills D, Wilke C, Hirawat S, Juric D; SOLAR-1 Study Group. André F, et al. N Engl J Med. 2019 May 16;380(20):1929-1940. doi: 10.1056/NEJMoa1813904. N Engl J Med. 2019. PMID: 31091374 Clinical Trial.
Lenvatinib: A Promising Molecular Targeted Agent for Multiple Cancers.
Suyama K, Iwase H. Suyama K, et al. Among authors: iwase h. Cancer Control. 2018 Jan-Dec;25(1):1073274818789361. doi: 10.1177/1073274818789361. Cancer Control. 2018. PMID: 30032643 Free PMC article. Review.
Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial.
Masuda N, Sagara Y, Kinoshita T, Iwata H, Nakamura S, Yanagita Y, Nishimura R, Iwase H, Kamigaki S, Takei H, Noguchi S. Masuda N, et al. Among authors: iwase h. Lancet Oncol. 2012 Apr;13(4):345-52. doi: 10.1016/S1470-2045(11)70373-4. Epub 2012 Jan 20. Lancet Oncol. 2012. PMID: 22265697 Clinical Trial.
PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind study.
Pegram MD, Bondarenko I, Zorzetto MMC, Hingmire S, Iwase H, Krivorotko PV, Lee KS, Li RK, Pikiel J, Aggarwal R, Ewesuedo R, Freyman A, Li R, Vana A, Yin D, Zacharchuk C, Tan-Chiu E. Pegram MD, et al. Among authors: iwase h. Br J Cancer. 2019 Jan;120(2):172-182. doi: 10.1038/s41416-018-0340-2. Epub 2018 Dec 20. Br J Cancer. 2019. PMID: 30568294 Free PMC article. Clinical Trial.
Differential predictive factors for cardiovascular events in patients with or without cancer history.
Sueta D, Tabata N, Ikeda S, Saito Y, Ozaki K, Sakata K, Matsumura T, Yamamoto-Ibusuki M, Murakami Y, Jodai T, Fukushima S, Yoshida N, Kamba T, Araki E, Iwase H, Fujii K, Ihn H, Kobayashi Y, Minamino T, Yamagishi M, Maemura K, Baba H, Matsui K, Tsujita K. Sueta D, et al. Among authors: iwase h. Medicine (Baltimore). 2019 Nov;98(44):e17602. doi: 10.1097/MD.0000000000017602. Medicine (Baltimore). 2019. PMID: 31689764 Free PMC article.
Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
Sueta A, Yamamoto Y, Tomiguchi M, Takeshita T, Yamamoto-Ibusuki M, Iwase H. Sueta A, et al. Among authors: iwase h. Oncotarget. 2017 Jul 22;8(41):69934-69944. doi: 10.18632/oncotarget.19482. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050253 Free PMC article.
Cancer Navigation Strategy for Endocrine Therapy-Resistant Breast Tumors.
Nakao M, Fujiwara S, Iwase H. Nakao M, et al. Among authors: iwase h. Trends Cancer. 2018 Jun;4(6):404-407. doi: 10.1016/j.trecan.2018.04.005. Epub 2018 May 19. Trends Cancer. 2018. PMID: 29860984 Review.
Comparison of quality of life between 2-year and 3-or-more-year administration of leuprorelin acetate every-3-months depot in combination with tamoxifen as adjuvant endocrine treatment in premenopausal patients with endocrine-responsive breast cancer: a randomized controlled trial.
Ohashi Y, Shiba E, Yamashita H, Kurebayashi J, Noguchi S, Iwase H, Yoshida M, Fujimoto T. Ohashi Y, et al. Among authors: iwase h. Support Care Cancer. 2018 Mar;26(3):933-945. doi: 10.1007/s00520-017-3914-2. Epub 2017 Oct 24. Support Care Cancer. 2018. PMID: 29063390 Free PMC article. Clinical Trial.
Roles of long noncoding RNAs in chromosome domains.
Tomita S, Abdalla MO, Fujiwara S, Yamamoto T, Iwase H, Nakao M, Saitoh N. Tomita S, et al. Among authors: iwase h. Wiley Interdiscip Rev RNA. 2017 Mar;8(2). doi: 10.1002/wrna.1384. Epub 2016 Aug 3. Wiley Interdiscip Rev RNA. 2017. PMID: 27489248 Review.
Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor.
Iwase H. Iwase H. Int J Clin Oncol. 2015 Apr;20(2):249-52. doi: 10.1007/s10147-015-0795-6. Epub 2015 Feb 10. Int J Clin Oncol. 2015. PMID: 25666484 Review. No abstract available.
161 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback